<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03724760</url>
  </required_header>
  <id_info>
    <org_study_id>0165-18-WOMC</org_study_id>
    <nct_id>NCT03724760</nct_id>
  </id_info>
  <brief_title>Pedometers for the Enhancement of Post Cesarean Mobility</brief_title>
  <official_title>Using Pedometers for the Enhancement of Post Caesarean Mobility in High Risk Patients Using a Personalized Repeated Feedback Approach - a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wolfson Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wolfson Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial, planned to study the effects of pedometers (digital
      step counters) on patient mobility following cesarean delivery. The investigators plan to
      randomize patients at high risk for thromboembolic events to participants with a personalized
      repeated feedback approach based on pedometer results, versus participants with no feedback
      to pedometer results.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 3, 2018</start_date>
  <completion_date type="Actual">July 30, 2019</completion_date>
  <primary_completion_date type="Actual">July 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of steps</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of steps taken by patient as recirded by pedometer</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with a postpartum complication composite</measure>
    <time_frame>48 hours</time_frame>
    <description>Composite of postpartum complications, including infectious (endometritis, wound), blood product transfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of analgesic doses</measure>
    <time_frame>48 hours</time_frame>
    <description>Number of doses of analgesics consumed by patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>From 72 hours to one week</time_frame>
    <description>Duration of postpartum hospitalization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of thromboembolic events</measure>
    <time_frame>Six weeks</time_frame>
    <description>Thromboembolic events during the post partum period, including deep vein thrombosis and pulmonary emboli</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">291</enrollment>
  <condition>Mobility Limitation</condition>
  <arm_group>
    <arm_group_label>Feedback</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this arm will wear a pedometer for two days following cesarean delivery. During this period, they will recieve feedback regrding the number of steps taken by them at two time points.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this arm will wear a pedometer for two days following cesarean delivery. During this period, they will recieve no feedback regrding the number of steps taken by them.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>personalized repeated feedback approach</intervention_name>
    <description>Feedback on number of steps taken by patint, as recorded by pedometers, provided by research team</description>
    <arm_group_label>Feedback</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients following cesarean delivery

          -  Consent to participation

          -  No medical recommendation for bed rest and limited mobility

          -  Meet any of the following criteria for high risk for thromboembolic complications -
             preeclampsia, chronic disease (reumatic, inflammatory bowel disease), obese, smoker &gt;
             10 cigaretts a day, age &gt;35, substantial limb varicose, multiple gestation,
             multiparity (&gt; deliveries), emergent surgery, thrombophilia.

        Exclusion Criteria:

          -  Refusal to participate

          -  Medical recommendation to limit mobility
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hadas Ganer Herman, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Obstetrics and Gynecology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Edith Wolfson Medical Center</name>
      <address>
        <city>Holon</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 29, 2018</study_first_submitted>
  <study_first_submitted_qc>October 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 30, 2018</study_first_posted>
  <last_update_submitted>November 3, 2019</last_update_submitted>
  <last_update_submitted_qc>November 3, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 5, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wolfson Medical Center</investigator_affiliation>
    <investigator_full_name>Hadas Ganer Herman</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mobility Limitation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

